One promising target for creating new anticancer medications is phosphatidyl-inositol-3-kinase (PI3K). Many human malignancies, including brain, colon, endometrial, breast, and prostate cancers, have been linked to PI3K dysregulation. The genes for PIK3CA, PIK... ...
